Accuracy of a continuous glucose monitoring system
Part of Hormones & metabolism clinical trials.
This trial tests a new continuous glucose monitor that checks blood sugar levels without frequent finger pricks. It aims to see how accurate and safe it is for people with type 1 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have type 1 diabetes.
- You can have a blood sample taken from your forearm.
- You can read and follow instructions, and you sign the consent form.
- You have not had severe low blood sugar in the past 6 months.
- You do not have conditions like heart failure, skin problems at the sensor site, blood disorders, or are not pregnant or planning pregnancy.
- You do not plan to have MRI or CT scans during the sensor wear.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
This trial tests a new device that measures blood sugar and ketones continuously. It may help people with type 1 diabetes who use an insulin pump keep better track of their levels.
This study asks people with diabetes to use a continuous glucose monitor (a small device that tracks blood sugar automatically) and share their thoughts about it. Researchers want to understand what features matter most to patients and how well the device works in real life.
This trial tests a new continuous glucose monitor (CGM) designed to help manage blood sugar levels. You will wear the device for 15 days and attend three clinic visits to see how well it works.
This study tests two new continuous glucose monitoring (CGM) systems—devices that track blood sugar levels throughout the day—to make sure they work accurately and safely. You'll wear both sensors for 17 days while visiting the clinic six times so researchers can compare the readings to blood tests.
This study tests a new continuous glucose monitor (CGM) that you wear for 14 days. It checks how accurate the device is and how well it helps track your blood sugar levels, all while being safe and easy to use.
Hear when a new Type1diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.